期刊文献+

雷帕霉素对小鼠T淋巴细胞的体外作用 被引量:2

Effects of rapamycin on proliferation,function and cell-cycle of mouse T lymphocytes in vitro
下载PDF
导出
摘要 目的研究雷帕霉素对小鼠T淋巴细胞体外的增殖、白细胞介素2(IL-2)表达及细胞周期的影响。方法将C57BL/6小鼠脾脏制备成脾单个核细胞,使用免疫磁珠法分选出小鼠T淋巴细胞。T细胞分别加入0、10、20、30和40ng/ml梯度浓度的雷帕霉素培养液培养72h后,采用MTT法及ELISA法测定各组细胞的增殖情况及IL-2表达情况;用流式细胞仪测定40ng/ml雷帕霉素浓度组及对照组(0ng/ml)细胞周期的变化情况。结果用雷帕霉素培养液培养细胞时,细胞增殖及IL-2的表达均受到抑制(P<0.01)。随药物浓度增加,细胞增殖及IL-2表达受抑制越明显(P<0.01);细胞周期分析显示加入雷帕霉素培养的T淋巴细胞与未使用药物刺激者相比,G0G1期细胞的比例升高(P<0.01),S期降低(P<0.01)。结论在体外雷帕霉素对小鼠T细胞的增殖、IL-2的表达起抑制作用,且随浓度增加,抑制作用增强;雷帕霉素将小鼠T细胞抑制在G0G1期。 Objective To investigate the effects of rapamycin on proliferation, levels of interleukin-2 (IL-2) and cell-cycle of mouse T lymphocytes in vitro. Methods Mononuclearcell from C57BL/6 mouse's spleen was prepared and the memory T cells were separated by Magnetic Cell Sorting System. Various concentrations of repamycin (0, 10, 20, 30 and 40 ng/ml) were used to culture the memory T cells for 72 hours. The activity of cells and levels of IL-2 were measured by methylthiazlyltetrazolium (MTT) assay. Results Proliferation of memory T cells and expression of IL-2 were suppressed in a dose-dependent manner by rapamycin medium when cultured with rapamycin (P〈0. 01). The cell population increseased in G0G1 phase (P〈0. 01) and decreased in S phase (P〈0. 01). Conclusion In vitro, rapamycin is a potential inhibitor that blocks the proliferation of memory T cells in Go G1 phase,and the expression of IL-2.
出处 《江苏医药》 CAS CSCD 北大核心 2008年第3期260-262,共3页 Jiangsu Medical Journal
基金 江苏省卫生厅135重点医学专科基金(RC2001002)
关键词 雷帕霉素 小鼠T细胞 增殖 白细胞介素2 细胞周期 Rapamycin Mouse T cells Proliferation Interleukin-2 Cell cycle
  • 相关文献

参考文献9

  • 1胡新华,杨军,刘程伟,张志深,张强.mTOR信号转导通路在自体移植静脉中的表达及意义[J].中华普通外科杂志,2006,21(12):889-892. 被引量:2
  • 2陈宏林,尤庆生,沈卫东,刘琨,孟小勇.雷帕霉素抑制兔自体移植静脉内膜过度增殖[J].江苏医药,2007,33(5):500-502. 被引量:1
  • 3Jones ND, Carvalho-Gaspar M, Luo S, et al. Effector and memory CD8^+ T cells can be generated in response to alloantigen independently of CD4^+ T cell help[J]. The Journal of Immunology,2006, 176(4) :2316-2323.
  • 4Monk NJ, Hargreaves RE, Simpson E, et al. Transplant tolerance: models, concepts and faets[J]. J Mol Med, 2006, 84 (4) : 295-304.
  • 5Raught B, Gingras AC, Sonenberg N. The target of rapamycin (TOR) proteins[J]. Proc Natl Acad Sci USA, 2001,98 (13) : 7037-7044.
  • 6Lechler RI, Sykes M, Thomson AW,et al. Organ transplantation-how much of the promise has been realized [J]? Nature Medcine, 2005,11(6) : 605-613.
  • 7Kato M, Watarai S, Nishika A, et al. A novel culture method of canine peripheral blood lymphocytes with concanavalin a and recombinant human interleukin-2 for adoptive immunotherapy [J]. J Vet Med Sci,2007,69(5) :481-486.
  • 8张莹,姚咏明,常青,董宁.不同细胞刺激剂对小鼠调节性T细胞功能活化的影响[J].中国危重病急救医学,2007,19(3):142-145. 被引量:14
  • 9Bingaman AW, Farber DL. Memory T cells in transplantation: generation, function, and potential role in rejection[J] . American Journal of Transplantation, 2004,4(6) : 846-852.

二级参考文献22

  • 1张莹,姚咏明.调节性T细胞与脓毒症关系的研究进展[J].中国危重病急救医学,2006,18(11):695-697. 被引量:18
  • 2Moses JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.N Engl J Med,2003,349:1315-1323.
  • 3Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med,2002,346:1773-1780.
  • 4Fingar DC,Richardson CJ,Tee AR,et al.mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.Mol Cell Biol,2004,24:200-216.
  • 5Martin KA,Rzucidlo EM,Merenick BL,et al.The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation.Am J Physiol Cell Physiol,2004,286:C507-C517.
  • 6June C H,Blazar B R. Clinical application of expanded CD4^+25^+cells [J]. Semin Immunol, 2006,18 (2) : 78 - 88.
  • 7D'Ambrosio D. Regulatory T cells:how do they find their space in the immunological arena [J]? Semin Cancer Biol, 2006,16 (2) :91 - 97.
  • 8Zheng S G, Meng L, Wang J H, et al. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4^+ CD25^+ cells in the recipient[J]. Int Immunol,2006,18(2) :279 - 289.
  • 9Fehervari Z,Sakaguchi S. Development and function of CD25^+CD4^+ regulatory T cells [J]. Curr Opin Immunol, 2004,16 (2) :203 - 208.
  • 10Zheng S G, Wang J H, Stohl W, et al. TGF - beta requires CTLA-4 early after T cell activation to induce Foxp3 and generate adaptive CD4^+CD25^+ regulatory cells [J]. J Immunol,2006,176(6):3321 -3329.

共引文献14

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部